DOWNLOAD THE PDF PRESS RELEASE HERE >

FOR IMMEDIATE RELEASE
July 30, 2026                  

THE EGYPTIAN-AMERICAN ENTERPRISE FUND ANNOUNCES SUCCESSFUL EXIT FROM ORCHIDIA PHARMACEUTICAL INDUSTRIES

NEW YORK, NY—The Egyptian-American Enterprise Fund (“EAEF”), a private investment fund established by the U.S. Congress to promote the development of the Egyptian private sector, has announced the successful sale of its indirect investment in Orchidia Pharmaceutical Industries S.A.E. (“Orchidia”), which operated through a holding company in Europe and is a leading ophthalmic pharmaceutical manufacturer with operations in Egypt, Africa and the Middle East.  

EAEF invested in Orchidia through Lorax Capital Partners (“Lorax”), a Cairo-based private equity firm that managed the investment throughout the holding period. The exit marks an important milestone for EAEF and reflects the significant growth and transformation Orchidia achieved during the investment period.

EAEF’s investment included capital to support the construction of the Company’s SDU line, among other strategic expansion initiatives. Since the time of investment, Orchidia has established a prominent presence in Egypt’s ophthalmology sector. The Company further extended its reach through new product launches, geographic expansion, and continued operational and manufacturing improvements. Orchidia now exports to 36 countries across the Middle East, Africa, Europe, and Eurasia, and has built a diversified portfolio of 125 actively marketed products spanning ophthalmology, nutraceuticals, and cosmetics. Throughout this period, the Company sustained strong profitability while continuing to invest in its people, facilities, and product pipeline.

“We are very pleased with the outcome of this investment and proud of what Orchidia has achieved over the holding period,” said James Harmon, Chairman of EAEF. “We would like to thank the Abbas family for their skilled leadership of the business throughout our partnership. Their dedication to growing Orchidia into a regional leader has been central to this success.  We also extend our appreciation to Lorax Capital Partners for their thoughtful stewardship of the investment and for guiding the business through a period marked by significant macroeconomic challenges. Together, this partnership helped position Orchidia for its next phase of growth, and we wish the Company continued success. “

 

–ENDS–

 

Press Contact
Egyptian-American Enterprise Fund
Cornelius Queen
cqueen@eaefund.org

About Orchidia Pharmaceutical Industries

Orchidia Pharmaceutical Industries S.A.E. specializes in ophthalmic pharmaceuticals with a state-of-the-art production facility. The Company has built a strong international presence across the Middle East, Africa, Europe, and Eurasia. For more information, visit orchidiapharma.com.

About the Egyptian-American Enterprise Fund 

The Egyptian-American Enterprise Fund is a private investment fund authorized by Congress in 2011 to promote the development of the Egyptian private sector. EAEF invests in local enterprises to maximize returns for U.S. taxpayers, mobilize foreign investment and support a healthy private sector that advances U.S. interests by making Egypt a more stable and prosperous partner. 

The Fund is comprised of an independent board of directors composed of three Egyptian citizens and six American citizens pursuant to its congressional legislation.  

This press release is made possible by the generous support of the American people through the U.S. government. 

The contents are the responsibility of the Egyptian-American Enterprise Fund and do not necessarily reflect the views of U.S. Department of State or the United States Government. Further details on EAEF can be found at https://www.eaefund.org. 

About Lorax Capital Partners

Lorax Capital Partners is a Cairo-based private equity firm managing investments across Egypt and the broader MENA region. The firm has a strong track record in growth investments, and its team has executed transactions worth more than USD 46 billion. Lorax partners with growth-oriented businesses to create sustainable value through operational improvements, governance enhancement, and strategic development. For more information, visit loraxcapitalpartners.com.